IL6 and COVID-19: This molecular fingerprint might help to anticipate hallmarks of pathophysiologically relevant clinical changes (i.e., Δ IL-6 as a surrogate for systemic inflammatory response and Δ D-Dimers as a surrogate for COVID-19 coagulopathy) in COVID-19 patients and help to better understand the underlying pathophysiological sequelae.